Global stem cell therapy market is segmented on the basis of therapy, and application. In terms of therapy, the market is segmented into autologous, and...
The global stem cell therapy market is experiencing growth due to increase in healthcare expenditure and surge in government support for R&D activities....
Increase in the prevalence of chronic diseases, advances in stem cell research, and growth in investment in regenerative medicine are prominent factors...
/PRNewswire/ -- In the near future, the stem cell manufacturing industry is poised to experience unprecedented growth and innovation, revolutionizing...
Increasing popularity of effective medications like beta-blockers, antiplatelet drugs, and statins is expected to drive critical limb ischemia treatment...
North America held largest share of global cell therapy market, which was valued at USD 7,820.35 million in 2020 and is expected to grow at a CAGR of 4.5%...
/PRNewswire/ -- The hematopoietic stem cells transplantation (HSCT) market size is set to grow by USD 2383.61 million between 2023 and 2027, and register a...
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and...
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and...
: The recent study on ‘Global Stem Cell Therapy Market’ provides readers with information on the forces promoting the industry’s expansion, impediments,...
/PRNewswire/ -- The "Global Stem Cells Market (2022-2027) by Product, Technology, Source, Applications, and Geography, with Competitive Analysis, Impact of...
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.